Clinical trial
Safety and Efficacy of Antegrade Flexible Ureteroscopy-Assisted Percutaneous Nephrolithotomy for Staghorn Calculi: A Prospective Multicenter Clinical Study
NCT07172373 is registered in ClinicalTrials.gov with Tianjin Medical University Second Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Antegrade Flexible Ureteroscopy-Assisted Percutaneous Nephrolithotomy for Staghorn Calculi: A Prospective Multicenter Clinical Study
- Lead sponsor
- Tianjin Medical University Second Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2025
- Completion date
- April 30, 2026
- Enrollment
- 420 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
renal stones, urolithiasis